• enVVeno Medical CEO Robert Berman will join a Virtual Investor Closing Bell event on June 9, 2026, at 4:00 PM ET.
• Discussion to focus on FDA IDE clearance for the enVVe System, enabling a U.S. pivotal study of a non-surgical replacement venous valve.
• Live Q&A session scheduled with audience participants.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. enVVeno Medical Corp. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202606020901ACCESSWRNAPR_____1172665) on June 02, 2026, and is solely responsible for the information contained therein.